Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vincent Rajkumar

Showing results (291-300 of 566) with videos related to

Pageof 57
Sort By:
Blood Cancer Journal|November 25, 2018
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research ProjectSaad Z Usmani, Antje Hoering, Michele Cavo, et al.
British Journal of Haematology|March 6, 2019
Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosisSurbhi Sidana, Nidhi Tandon, Morie A Gertz, et al.
Blood Cancer Journal|January 16, 2024
Mode of progression in smoldering multiple myeloma: a study of 406 patientsNadine H Abdallah, Arjun Lakshman, Shaji K Kumar, et al.
Blood|September 2, 2011
The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndromeAnita D'Souza, Suzanne R Hayman, Francis Buadi, et al.
American Journal of Hematology|July 7, 2015
Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myelomaMoritz Binder, S Vincent Rajkumar, Morie A Gertz, et al.
Blood Cancer Journal|April 15, 2020
A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosisSurbhi Sidana, Paolo Milani, Moritz Binder, et al.
Blood|September 30, 2006
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosisAngela Dispenzieri, Martha Q Lacy, Steven R Zeldenrust, et al.
Blood|February 21, 2013
Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approachAngela Baker, Esteban Braggio, Susanna Jacobus, et al.
American Journal of Hematology|June 19, 2023
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL)Alissa Visram, Suzanne R Hayman, Angela Dispenzieri, et al.
Blood|December 24, 2005
Clinical implication of centrosome amplification in plasma cell neoplasmWee J Chng, Greg J Ahmann, Kim Henderson, et al.
Pageof 57

Showing results (291-300 of 566) with videos related to

Sort By:
Pageof 57
Blood Cancer Journal|November 25, 2018
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research ProjectSaad Z Usmani, Antje Hoering, Michele Cavo, et al.
British Journal of Haematology|March 6, 2019
Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosisSurbhi Sidana, Nidhi Tandon, Morie A Gertz, et al.
Blood Cancer Journal|January 16, 2024
Mode of progression in smoldering multiple myeloma: a study of 406 patientsNadine H Abdallah, Arjun Lakshman, Shaji K Kumar, et al.
Blood|September 2, 2011
The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndromeAnita D'Souza, Suzanne R Hayman, Francis Buadi, et al.
American Journal of Hematology|July 7, 2015
Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myelomaMoritz Binder, S Vincent Rajkumar, Morie A Gertz, et al.
Blood Cancer Journal|April 15, 2020
A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosisSurbhi Sidana, Paolo Milani, Moritz Binder, et al.
Blood|September 30, 2006
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosisAngela Dispenzieri, Martha Q Lacy, Steven R Zeldenrust, et al.
Blood|February 21, 2013
Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approachAngela Baker, Esteban Braggio, Susanna Jacobus, et al.
American Journal of Hematology|June 19, 2023
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL)Alissa Visram, Suzanne R Hayman, Angela Dispenzieri, et al.
Blood|December 24, 2005
Clinical implication of centrosome amplification in plasma cell neoplasmWee J Chng, Greg J Ahmann, Kim Henderson, et al.
Pageof 57